Concentra Biosciences to acquire IGM Biosciences for $82m.

Concentra Biosciences, a provider of clinical and business development services, offered to acquire IGM Biosciences, a biotechnology company, for $82m. The IGM Biosciences Board of Directors has unanimously determined that the acquisition by Concentra is in the best interests of all IGM Biosciences stockholders and has approved the Merger Agreement and related transactions.